Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.

Hepatic dysfunction is one of the clinical features in severe malaria. However, the mechanism of hepatic injury during malaria is still unknown. Myeloid-related protein (MRP) 14 is abundantly expressed by myeloid cells and involved in various inflammatory diseases. We previously reported that serum...

Full description

Saved in:
Bibliographic Details
Main Authors: Haruka Mizobuchi, Wataru Fujii, Shoko Isokawa, Kanna Ishizuka, Yihan Wang, Sayoko Watanabe, Chizu Sanjoba, Yoshitsugu Matsumoto, Yasuyuki Goto
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199111&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850078785763803136
author Haruka Mizobuchi
Wataru Fujii
Shoko Isokawa
Kanna Ishizuka
Yihan Wang
Sayoko Watanabe
Chizu Sanjoba
Yoshitsugu Matsumoto
Yasuyuki Goto
author_facet Haruka Mizobuchi
Wataru Fujii
Shoko Isokawa
Kanna Ishizuka
Yihan Wang
Sayoko Watanabe
Chizu Sanjoba
Yoshitsugu Matsumoto
Yasuyuki Goto
author_sort Haruka Mizobuchi
collection DOAJ
description Hepatic dysfunction is one of the clinical features in severe malaria. However, the mechanism of hepatic injury during malaria is still unknown. Myeloid-related protein (MRP) 14 is abundantly expressed by myeloid cells and involved in various inflammatory diseases. We previously reported that serum MRP14 is elevated in mice infected with Plasmodium berghei ANKA. In order to verify whether extracellular MRP14 is involved in the pathology of hepatic injury during rodent malaria, we intravenously administrated recombinant MRP14 (rMRP14) to mice infected with P. berghei ANKA. The administration of rMRP14 did not affect parasite number or hematocrit. On the other hand, the hepatic injury was exacerbated in rMRP14-treated mice, and their serum concentration of hepatic enzymes increased significantly more than PBS-treated controls. Immunohistochemical analysis of the liver showed that more MRP14+ macrophages accumulated in rMRP14-treated mice than PBS-treated controls after infection. The administration of rMRP14 also promotes the up-regulation of pro-inflammatory molecules in the liver, such as iNOS, IL-1β, IL-12, and TNF-α. Even in the absence of Plasmodium infection, administration of rMRP14 could induce the accumulation of MRP14+ macrophages and up-regulation of the pro-inflammatory molecules in the liver of naïve mice. The results indicate that MRP14 promotes the accumulation of MRP14+ cells and the up-regulation of pro-inflammatory molecules and NO, which amplify inflammatory cascade leading to hepatic injury. In conclusion, MRP14 is a one of key molecules for liver inflammation during rodent malaria.
format Article
id doaj-art-1c944aabfda54c1fb9e49a276d0fb3c8
institution DOAJ
issn 1932-6203
language English
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-1c944aabfda54c1fb9e49a276d0fb3c82025-08-20T02:45:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01136e019911110.1371/journal.pone.0199111Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.Haruka MizobuchiWataru FujiiShoko IsokawaKanna IshizukaYihan WangSayoko WatanabeChizu SanjobaYoshitsugu MatsumotoYasuyuki GotoHepatic dysfunction is one of the clinical features in severe malaria. However, the mechanism of hepatic injury during malaria is still unknown. Myeloid-related protein (MRP) 14 is abundantly expressed by myeloid cells and involved in various inflammatory diseases. We previously reported that serum MRP14 is elevated in mice infected with Plasmodium berghei ANKA. In order to verify whether extracellular MRP14 is involved in the pathology of hepatic injury during rodent malaria, we intravenously administrated recombinant MRP14 (rMRP14) to mice infected with P. berghei ANKA. The administration of rMRP14 did not affect parasite number or hematocrit. On the other hand, the hepatic injury was exacerbated in rMRP14-treated mice, and their serum concentration of hepatic enzymes increased significantly more than PBS-treated controls. Immunohistochemical analysis of the liver showed that more MRP14+ macrophages accumulated in rMRP14-treated mice than PBS-treated controls after infection. The administration of rMRP14 also promotes the up-regulation of pro-inflammatory molecules in the liver, such as iNOS, IL-1β, IL-12, and TNF-α. Even in the absence of Plasmodium infection, administration of rMRP14 could induce the accumulation of MRP14+ macrophages and up-regulation of the pro-inflammatory molecules in the liver of naïve mice. The results indicate that MRP14 promotes the accumulation of MRP14+ cells and the up-regulation of pro-inflammatory molecules and NO, which amplify inflammatory cascade leading to hepatic injury. In conclusion, MRP14 is a one of key molecules for liver inflammation during rodent malaria.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199111&type=printable
spellingShingle Haruka Mizobuchi
Wataru Fujii
Shoko Isokawa
Kanna Ishizuka
Yihan Wang
Sayoko Watanabe
Chizu Sanjoba
Yoshitsugu Matsumoto
Yasuyuki Goto
Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.
PLoS ONE
title Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.
title_full Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.
title_fullStr Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.
title_full_unstemmed Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.
title_short Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.
title_sort exacerbation of hepatic injury during rodent malaria by myeloid related protein 14
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199111&type=printable
work_keys_str_mv AT harukamizobuchi exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT watarufujii exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT shokoisokawa exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT kannaishizuka exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT yihanwang exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT sayokowatanabe exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT chizusanjoba exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT yoshitsugumatsumoto exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14
AT yasuyukigoto exacerbationofhepaticinjuryduringrodentmalariabymyeloidrelatedprotein14